|
ZNF701 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.60140000049891E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84420000000274E-05 |
| Normal-vs-Stage2 |
1.38920000003484E-06 |
| Normal-vs-Stage3 |
5.72770000000222E-05 |
| Normal-vs-Stage4 |
1.15180000004322E-06 |
| Stage1-vs-Stage2 |
4.873600E-02 |
| Stage1-vs-Stage3 |
5.742400E-01 |
| Stage1-vs-Stage4 |
7.449800E-02 |
| Stage2-vs-Stage3 |
1.597010E-01 |
| Stage2-vs-Stage4 |
6.185200E-01 |
| Stage3-vs-Stage4 |
2.819400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63516999999169E-05 |
| Normal-vs-AfricanAmerican |
1.641950E-02 |
| Normal-vs-Asian |
5.580100E-04 |
| Caucasian-vs-AfricanAmerican |
6.474600E-01 |
| Caucasian-vs-Asian |
8.986000E-01 |
| AfricanAmerican-vs-Asian |
6.135600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.13249999944954E-07 |
| Normal-vs-Female |
3.30690000005518E-06 |
| Male-vs-Female |
4.579400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.777490E-04 |
| Normal-vs-Age(41-60Yrs) |
8.64849999948625E-07 |
| Normal-vs-Age(61-80Yrs) |
1.70496999999381E-05 |
| Normal-vs-Age(81-100Yrs) |
2.193800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.378370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.501640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.319800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.167200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.821200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.556000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.898600E-01 |
| Classical-VS-Follicular |
3.960400E-04 |
| Classical-VS-Other |
3.259400E-01 |
| Classical-VS-Normal |
8.38780000000927E-05 |
| Tall-VS-Follicular |
5.586200E-02 |
| Tall-VS-Other |
4.402800E-01 |
| Tall-VS-Normal |
3.164100E-03 |
| Follicular-VS-Other |
8.408800E-01 |
| Follicular-VS-Normal |
1.53240000022592E-07 |
| Other-VS-Normal |
2.470500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.36890000007806E-07 |
| Normal-vs-N1 |
1.659210E-03 |
| N0-vs-N1 |
4.531200E-01 |
|
|
